No headlines found.
United-Guardian Reports 2025 Financial Results
Globe Newswire (Fri, 27-Mar 9:00 AM ET)
United-Guardian Declares Cash Dividend
Globe Newswire (Thu, 29-Jan 9:00 AM ET)
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.
United-Guardian trades on the NASDAQ stock market under the symbol UG.
As of April 22, 2026, UG stock price climbed to $6.75 with 3,385 million shares trading.
UG has a market cap of $31.01 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, UG traded as high as $16.25 and as low as $5.58.
The top ETF exchange traded funds that UG belongs to (by Net Assets): VTI, VXF, DFMC, DFAS, IWC.
UG has underperformed the market in the last year with a price return of -15.1% while the SPY ETF gained +39.8%. However, in the short term, UG had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.2% vs +4.0% return in SPY. But in the last 2 weeks, UG shares have been beat by the market, returning +1.0% compared to an SPY return of +7.9%.
UG support price is $6.48 and resistance is $6.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UG shares will trade within this expected range on the day.
